Dr. Cabebe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2589 Samaritan Dr
San Jose, CA 95124Phone+1 408-426-4900
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2005 - 2008
Santa Clara Valley Medical CenterResidency, Internal Medicine, 2002 - 2005
University of Vermont College of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2003 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 40 citationsSunitinib: a newly approved small-molecule inhibitor of angiogenesis.Elwyn Cabebe, Heather A. Wakelee
Drugs of Today. 2006-06-01 - 99 citationsRole of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors.Elwyn Cabebe, Heather A. Wakelee
Current Treatment Options in Oncology. 2007-06-08 - 73 citationsDurvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.Jacqueline V. Aredo, Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal
Journal of Thoracic Oncology. 2021-06-01
Press Mentions
Community Centers Take up Lung Screening TorchFebruary 10th, 2016
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
